Philippe Foubert is a strategic biotech and pharma leader with over 15 years of experience in translational medicine, preclinical, biomarker, and clinical development, focused on advancing innovative therapies for oncology. They have held key roles in notable organizations, including Director of Tumor Microenvironment Translational Biomarkers at Bristol Myers Squibb and Senior Director of Early Development Asset Lead Oncology at Ipsen. Philippe has a strong track record in leading biologics and cell therapy drug development, as well as expertise in immunotherapy and regenerative medicine. They earned a PhD in Biology and Pharmacology from Université Denis Diderot (Paris VII), where they researched proangiogenic cell therapy for ischemic diseases.
This person is not in any teams
This person is not in any offices